Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

被引:0
|
作者
Katsunori Nonogaki
Alison M. Strack
Mary F. Dallman
Laurence H. Tecott
机构
[1] University of California at San Francisco,Department of Psychiatry and Center for Neurobiology and Psychiatry
[2] University of California at San Francisco,Department of Physiology
[3] Merck Research Laboratories,undefined
[4] Merck & Co.,undefined
来源
Nature Medicine | 1998年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Brain serotonin and leptin signaling contribute substantially to the regulation of feeding and energy expenditure. Here we show that young adult mice with a targeted mutation of the serotonin 5-HT2C receptor gene consume more food despite normal responses to exogenous leptin administration. Chronic hyperphagia leads to a 'middle-aged'-onset obesity associated with a partial leptin resistance of late onset. In addition, older mice develop insulin resistance and impaired glucose tolerance. Mutant mice also responded more to high-fat feeding, leading to hyperglycemia without hyperlipidemia. These findings demonstrate a dissociation of serotonin and leptin signaling in the regulation of feeding and indicate that a perturbation of brain serotonin systems can predispose to type 2 diabetes.
引用
收藏
页码:1152 / 1156
页数:4
相关论文
共 50 条
  • [41] Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation
    Pälvimäki, EP
    Majasuo, H
    Kuoppamäki, M
    Männistö, PT
    Syvälahti, E
    Hietala, J
    PSYCHOPHARMACOLOGY, 1998, 136 (02) : 99 - 104
  • [42] Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT2c receptor mutant mice
    Nonogaki, K
    Abdallah, L
    Goulding, EH
    Bonasera, SJ
    Tecott, LH
    DIABETES, 2003, 52 (02) : 315 - 320
  • [43] Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice
    Vickers, SP
    Clifton, PG
    Dourish, CT
    Tecott, LH
    PSYCHOPHARMACOLOGY, 1999, 143 (03) : 309 - 314
  • [44] Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT2c receptor mutant mice
    Nonogaki, K
    Feingold, KR
    Tecott, LH
    DIABETES, 2002, 51 : A419 - A419
  • [45] Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice
    Steven P. Vickers
    Peter G. Clifton
    Colin T. Dourish
    Laurence H. Tecott
    Psychopharmacology, 1999, 143 : 309 - 314
  • [46] Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers
    Kamal, Maud
    Gbahou, Florence
    Guillaume, Jean-Luc
    Daulat, Avais M.
    Benleulmi-Chaachoua, Abla
    Luka, Marine
    Chen, Patty
    Anaraki, Dina Kalbasi
    Baroncini, Marc
    la Cour, Clotilde Mannoury
    Millan, Mark J.
    Prevot, Vincent
    Delagrange, Philippe
    Jockers, Ralf
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (18) : 11537 - 11546
  • [47] Ligand-directed serotonin 5-HT2C receptor desensitization and sensitization
    Felsing, Daniel E.
    Canal, Clinton E.
    Booth, Raymond G.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 848 : 131 - 139
  • [48] EATING DISORDER AND EPILEPSY IN MICE LACKING 5-HT2C SEROTONIN RECEPTORS
    TECOTT, LH
    SUN, LM
    AKANA, SF
    STRACK, AM
    LOWENSTEIN, DH
    DALLMAN, MF
    JULIUS, D
    NATURE, 1995, 374 (6522) : 542 - 546
  • [49] Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor
    Herrick-Davis, K
    Grinde, E
    Gauthier, C
    Teitler, M
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 140 - 145
  • [50] Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions
    Kristiansen, K
    Dahl, SG
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 306 (1-3) : 195 - 210